Endogena Therapeutics, Inc
1 clinical trials · Sponsor
◉ Watch Endogena Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosa (NCT05392751) | Endogena Therapeutics, Inc | 2022-06-02 |
Track Endogena Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.